PHENTALENE (TM), PHARMACEUTICAL GRADE, With 50 mg of Ephedra Extract, 90 CAPSULES
Recalling firm: Beta Labs
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Dec 3, 2014.
Check your package
Compare the exact product and package details with the label you have.
670541599822FDA code information
Lot # 58800512, Exp 05/16
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
PHENTALENE (TM), PHARMACEUTICAL GRADE, With 50 mg of Ephedra Extract, 90 CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599822
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| UPC | 670541599822 | dra Extract, 90 CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599822 |
| lot | 58800512 | Lot # 58800512, Exp 05/16 |
Original FDA recall reason
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Recall details
- Recall number
- F-2399-2014
- Event ID
- 65585
- FDA status
- Terminated
- Initiated
- Jun 20, 2013
- Reported
- Sep 3, 2014
- Classified
- Aug 27, 2014
- Terminated
- Dec 3, 2014
- Quantity
- 2154 units
- Location
- Memphis, TN, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Press Release
Where it was distributed
nationwide and UK
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.